These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32446873)

  • 61. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Noncovalent Complexation of Amphotericin B with Poly(β-Amino Ester) Derivates for Treatment of
    Yu Y; Peng L; Liao G; Chen Z; Li C
    Polymers (Basel); 2019 Feb; 11(2):. PubMed ID: 30960254
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
    Usman F; Nopparat J; Javed I; Srichana T
    Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Getting the Jump on the Development of Bullfrog Oil Microemulsions: a Nanocarrier for Amphotericin B Intended for Antifungal Treatment.
    Oliveira WN; Amaral-Machado L; Alencar EN; Marcelino HR; Genre J; Silva-Rocha WP; Gondim AD; Chaves GM; Fernandes-Pedrosa MF; Egito EST
    AAPS PharmSciTech; 2018 Aug; 19(6):2585-2597. PubMed ID: 29916194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.
    Saint-Julien L; Joly V; Seman M; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2722-8. PubMed ID: 1482139
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.
    Chéron M; Petit C; Bolard J; Gaboriau F
    J Antimicrob Chemother; 2003 Dec; 52(6):904-10. PubMed ID: 14613963
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetics of liposomal amphotericin B during extracorporeal albumin dialysis.
    Vogelsinger H; Joannidis M; Kountchev J; Bellmann-Weiler R; Wiedermann CJ; Bellmann R
    Artif Organs; 2006 Feb; 30(2):118-21. PubMed ID: 16433846
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A double-blinded, placebo-controlled, multicenter clinical trial of N-acetylcysteine for preventing amphotericin B-induced nephrotoxicity.
    Karimzadeh I; Khalili H; Sagheb MM; Farsaei S
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1345-55. PubMed ID: 26050706
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
    mBio; 2019 May; 10(3):. PubMed ID: 31138748
    [No Abstract]   [Full Text] [Related]  

  • 72. Lipid formulations of amphotericin B as first-line treatment of zygomycosis.
    Petrikkos GL
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():87-92. PubMed ID: 19754765
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis.
    Ribeiro NQ; Santos APN; Emídio ECP; Costa MC; Freitas GJC; Carmo PHF; Silva MF; de Brito CB; de Souza DG; Paixão TA; Santos DA
    Int J Antimicrob Agents; 2019 Sep; 54(3):301-308. PubMed ID: 31279153
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment.
    Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E;
    Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.
    Wasan KM; Conklin JS
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1806-10. PubMed ID: 8843285
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.
    Rolón M; Serrano DR; Lalatsa A; de Pablo E; Torrado JJ; Ballesteros MP; Healy AM; Vega C; Coronel C; Bolás-Fernández F; Dea-Ayuela MA
    Mol Pharm; 2017 Apr; 14(4):1095-1106. PubMed ID: 28198632
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biophysical and molecular docking approaches for the investigation of biomolecular interactions between amphotericin B and bovine serum albumin.
    Raza M; Ahmad A; Yue F; Khan Z; Jiang Y; Wei Y; Raza S; He WW; Khan FU; Qipeng Y
    J Photochem Photobiol B; 2017 May; 170():6-15. PubMed ID: 28364684
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
    Tiyaboonchai W; Limpeanchob N
    Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents.
    Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A
    Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improved antifungal activity of amphotericin B-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.
    Tang X; Jiao R; Xie C; Xu L; Huo Z; Dai J; Qian Y; Xu W; Hou W; Wang J; Liang Y
    Int J Clin Exp Med; 2015; 8(4):5150-62. PubMed ID: 26131089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.